Cancer Immunotherapy & Biofluid Biopsies 2016

Key Topics

• Checkpoint and Non-Checkpoint Immunotherapies
• Biomarkers & Companion Diagnostics for Immunotherapy
• Circulating Biomarkers for Monitoring Disease Progression and Treatment Outcomes: Circulating Cell-Free DNA (cfDNA), Circulating Tumor Cells (CTCs), Extracellular Vesicles (EVs): Exosomes and Microvesicles as Circulating Biomarker Carriers
• Chimeric Antigen Receptor (CAR) T-Cells in Cancer Immunotherapy: CAR T-Cell Design
• Costimulatory Molecules for Immunological Activation & Therapeutic Intervention: CD28 and others
• Combination Cancer Immunotherapy
• Liquid Biopsies for Minimally-Invasive Diagnostics
• Immunomodulatory Antibodies
• New and Emerging Targets for Immunological Intervention in Cancer: PD-1/PDL-1
• Natural Killer (NK) Cells in Cancer Immunotherapy
• Peptide Vaccines
• Oncolytic Viruses as Cancer Immunotherapeutics
• Small Molecules in Cancer Immune Therapy: Clinical Results, Mechanisms of Action
• Preclinical Animal Models for Immuno-Oncology
• Targeting the Tumor Microenvironment
• Targeting Signaling Pathways in Cancer as Therapeutic Intervention